Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

Overview of attention for article published in Quality of Life Research, December 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 77 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,457 followers.

Open Access UCL Research: Measuring what matters MOST: Validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer (ROC) https://t.co/DLbYB7XwNv

17 Dec 2018

Reply Repost Favourite

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer. https://t.co/eWtu6KInAS

15 Aug 2018

Reply Repost Favourite

28 Mar 2018

Reply Repost Favourite

#HealthEconJA Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer https://t.co/NkPJb1Lt6j

16 Dec 2017

Reply Repost Favourite